Tenofovir Disoproxil Fumarate 300 MG

DRUG3 trials

Sponsors

Third Affiliated Hospital, Sun Yat-Sen University, Yung Shin Pharm. Ind. Co., Ltd., University of North Carolina, Chapel Hill

Conditions

Chronic Hepatitis BHepatitis BPharmacokinetic of Tenofovir in Healthy SubjectsVertical Transmission of Infectious Disease

Phase 4

Pharmacokinetics of Two Formulation of Tenofovir Disoproxil Fumarate

CompletedNCT04671563

Yung Shin Pharm. Ind. Co., Ltd.Pharmacokinetic of Tenofovir in Healthy Subjects

Start: 2019-04-22End: 2020-08-31Updated: 2020-12-17

The COMBAT HBV Feasibility Trial

CompletedNCT05705427

University of North Carolina, Chapel HillHepatitis B, Vertical Transmission of Infectious Disease

Start: 2023-08-17End: 2025-11-25Updated: 2026-02-19

Unknown Phase

TDF Combined With LDT for the Treatment of HBeAg-positive Hepatitis B Patients With Poor Response to TDF for 12 Months

Third Affiliated Hospital, Sun Yat-Sen UniversityChronic Hepatitis B

Start: 2020-12-01End: 2022-12-30Target: 200Updated: 2021-01-12